
Fatty Acids and Lypidic Derivatives
Fatty acids are molecules composed of a long hydrocarbon chain with a carboxyl (-COOH) group at one end. These structures grant them a high capacity to interact with cell membranes and play key roles in energy metabolism, fat storage, and hormonal regulation. Fatty acid derivatives are used in cosmetics, pharmaceuticals, and as components in the production of biofuels.
At CymitQuimica, we offer fatty acids and their derivatives for applications in organic chemistry, biochemistry, and pharmaceutical development.
Found 32402 products of "Fatty Acids and Lypidic Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
L-Hydantoin-5-propionic Acid
CAS:Controlled ProductFormula:C6H8N2O4Color and Shape:NeatMolecular weight:172.142-Hydroxypropyl Nortadalafil (Mixture of Diastereomers)
CAS:Controlled Product<p>Applications 2-Hydroxypropyl Nortadalafil is a derivative of Tadalafil (T004500), which is used for the treatment of erectile dysfunction. A phosphodiesterase 5 inhibitor.<br>References Carrier, S., et al.: Can. J. Urol., 10(1), 12 (2003), Doggrell, S.A., et al.: Expert Opin. Pharmacother., 6, 75 (2005), Forgue, S.T., et al.: Br. J. Clin. Pharmacol., 61, 280 (2005), Toomey, V. et al.: J. Pharm. Biomed. Anal., 59, 50 (2012);<br></p>Formula:C24H23N3O5Color and Shape:NeatMolecular weight:433.46Fluvastatin 3-Hydroxy-4,6-diene Sodium Salt
CAS:Controlled Product<p>Stability Hygroscopic, Light Sensitive, Temperature Sensitive<br>Applications Fluvastatin 3-Hydroxy-4,6-diene Sodium Salt is a metabolite of Fluvastatin (F601250), a synthetic HMG-CoA reductase inhibitor. Antilipemic.<br>References Yuan, J., et al.: Atherosclerosis, 87, 147 (1991), Tse, F.L.S., et al.: J. Clin. Pharmacol., 32, 630 (1992), Dain, J.G., et al.: Drug Metab. Disposit., 21, 567 (1993),<br></p>Formula:C24H23FNNaO3Color and Shape:NeatMolecular weight:415.43Perfluorododecanoic Acid
CAS:Controlled Product<p>Applications Perfluorododecanoic Acid is fluorinated pollutant found in wastewater and industrial runoff. Potential risk factor for coronary heart disease.<br>References Mattsson, K. et al.: Env. Res., 142, 148 (2015); Yuan, G. et al.: Env. Sci. Tech., 50, 942 (2016);<br></p>Formula:C12HF23O2Color and Shape:White To Off-WhiteMolecular weight:614.103-(carboxymethyl)-1,2,3-oxadiazol-3-ium-5-olate
CAS:Formula:C4H4N2O4Purity:95.0%Color and Shape:SolidMolecular weight:144.0862,3-Pyridinedicarboxylic Acid-d3 (Major)
CAS:Controlled Product<p>Applications A labelled inhibitor of glucose synthesis.<br>References Garcia-Salguero, L. et al.: Arch. Int. Physiol., Biochim. Biophys., 99, 237, (1991); Martirosyan, A., et al.: Biochem. Pharmacol., 68, 1729 (2004);<br></p>Formula:C7D3H2NO4Color and Shape:NeatMolecular weight:170.14N-Formyl-L-leucine
CAS:Controlled Product<p>Applications A synthetic substrate of the lipase inhibitor lipstatin.<br>References Eisenreich, W., et al.: J. Biol. Chem., 272, 867 (1997), Goese, M., et al.: J. Biol. Chem., 275, 21192 (2000).<br></p>Formula:C7H13NO3Color and Shape:NeatMolecular weight:159.181-(2,2,2-trifluoroethyl)-1H-pyrazole-3-carboxylic acid
CAS:Purity:95.0%Molecular weight:194.11300659179688Taurultam
CAS:Controlled Product<p>Applications Taurultam is a compound that inhibits cell proliferation and cell adhesion in angiogenesis. Taurultam exhibits bacteriocidal effects on Escherichia coli and is also a degradation product of Taurolidine (T009050).<br>References Jones, D., et al.: Lett. Appl. Micro., 14, 5 (1992); Kirsch, L. & Sinn, Y.: Pharm. Dev. Tech., 2, 345 (1997); Mšhler, T., et al.: Cancer Therapy, 6, 623 (2008)<br></p>Formula:C3H8N2O2SColor and Shape:White To Off-WhiteMolecular weight:136.173-Bromo-6-chloroimidazo[1,2-a]pyridine-2-carboxylic acid
CAS:Purity:97.0%Molecular weight:275.489990234375N-(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)glycyl-L-proline
CAS:Controlled Product<p>Applications N-(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)glycyl-L-proline, is a metabolite of Vildagliptin (V305000), a class of oral anti-hyperglycemic agents that inhibit dipeptidyl peptidase 4 (DPP-4), which can act as a serine exopeptidase.<br>References Ahren, B., et al.: J. Clin. Endocrinol. Metab., 89, 2078 (2004), Ahren, B., et al.: Diabetes Care, 27, 2874 (2004), Barlocco, D., et al.: Curr. Opin. Invest. Drugs, 5, 1094 (2004),<br></p>Formula:C17H26N2O4Color and Shape:NeatMolecular weight:322.399Tadalafil Ketolactam (>90%)
CAS:Controlled Product<p>Stability Hygroscopic, Unstable in Solution<br>Applications Tadalafil Ketolactam is a Tadalafil (T004500) impurity.<br></p>Formula:C22H19N3O6Purity:>90%Color and Shape:NeatMolecular weight:421.40286-Cyclopropyl-3-methyl-isoxazolo[5,4-b]pyridine-4-carboxylic acid
CAS:Purity:95.0%Molecular weight:218.212005615234384-Hydroxy Atorvastatin Disodium Salt
CAS:<p>Applications A metabolite of Atorvastatin, a selective, competitive HMG-CoA reductase inhibitor. Atorvastatin is the only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia.<br>References Smith, S., et al.: Am. J. Cardiol., 80, 10H (1997), Jacobsen, W., et al.: Drug Metab. Dispos., 28, 1369 (2000), Istvan, E., et al.: Science, 292, 1160 (2001), Tabernero, L., et al.: J. Biol. Chem., 278, 19933 (2003), Bratton, L., et al.: Bioorg. Med. Chem., 15, 5576 (2007),<br></p>Formula:C33H33FN2Na2O6Color and Shape:White To BrownMolecular weight:618.60(3’S,3R,4S)-Desfluoro Ezetimibe
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications (3’S,3R,4S)-Desfluoro Ezetimibe is an impurity of the cholesterol absorption inhibitor Ezetimibe (E975000).<br>References Gajjar, A.K., Open. Con. Proceed. J., 2, 108 (2011);<br></p>Formula:C24H22FNO3Color and Shape:NeatMolecular weight:391.43Glycolic Acid-13C2
CAS:Controlled Product<p>Applications Labelled Glycolic Acid (G645600). Constituent of sugar cane juice.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Smyth, H.F., et al.: J. Ind. Hyg. Toxicol., 23, 259 (1941),<br></p>Formula:C2H4O3Color and Shape:NeatMolecular weight:78.04Ezetimibe Phenoxy β-D-Glucuronide
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Phase-II metabolite of Ezetimibe, an antihyperlipoproteinemic. A Cholesterol absorption inhibitor.This compound is very hygroscopic. Handle with care.<br>References van Heek, M., at al.: J. Pharmacol. Exp. Ther., 283, 157 (1997), van Heek, M., at al.: Brit. J. Pharmacol., 129, 1748 (2000)<br></p>Formula:C30H29F2NO9Color and Shape:White To Light BrownMolecular weight:585.55(8-Benzyl-2,4-dioxo-1,3,8-triaza-spiro[4.5]dec-3-yl)-acetic acid
CAS:Purity:95.0%Molecular weight:317.3450012207031

